Valdonė Misevičienė

Prof. Dr. Valdonė Misevičienė

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
BTBianca Tesi
Bianca Tesi
JRJelena Rascon
Jelena Rascon
SCSamuel C.C. Chiang
Samuel C.C. Chiang
BBBirute Burnyte
Birute Burnyte
ALAlexandra Löfstedt
Alexandra Löfstedt
YBYenan T. Bryceson
Yenan T. Bryceson

28 May 2025 in Medicina
Verified
Journal Article
Open access
PDF file
DBDovydas Burkojus
Dovydas Burkojus
GGGiedrė Gelžinienė
Giedrė Gelžinienė
EPEvelina Pajėdienė
Evelina Pajėdienė
GSGineta Stankevičienė
Gineta Stankevičienė
VMValdonė Misevičienė
Valdonė Misevičienė
GJGiedrė Jurkevičienė
Giedrė Jurkevičienė
The importance of sleep has been reported for decades. Epilepsy is a heterogeneous disorder comprising multiple elements that might influence sleep and wakefulness. Notably, animal studies show disruptions of the circadian molecular system in different models of epilepsy, along with altered rest–activity and other circadian rhythms. So far, studies of molecular circadian systems in people with epilepsy are lacking, prompting further research. Seizures—the primary and most debilitating symptom of epilepsy—and interictal activity disrupt regular sleep and sleep–wake rhythms. Alterations in one’s sleep structure are seen in both drug-naïve and drug-resistant patients with epilepsy. In particular, low sleep efficiency, a reduction in total sleep time, and changes in sleep stages were found in both homogenous and mixed samples of epilepsy patients. Both ictal and interictal activity were also shown to be associated with changes in peripheral circadian phase biomarkers such as melatonin and cortisol. Moreover, epilepsy comorbidities, antiseizure medications, and a variety of syndromes can be a cause of sleep problems or even sleep disorders. Sleep disorders vary depending on various comorbidities and syndromes, and encompass all major groups of sleep disorders defined in the International Classification of Sleep Disorders. Controversial findings on the effects of various antiseizure medications were found in the literature. However, medications such as benzodiazepines, gabapentinoids, and barbiturates are particularly associated with excessive daytime sleepiness. Overall, a sleep evaluation must be included in the management of every patient with epilepsy.

7 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
GOGintare Oboleviciene
Gintare Oboleviciene
VMViktorija Mejeryte
Viktorija Mejeryte
NJNorvile Jotautaite
Norvile Jotautaite
EREgle Rinkeviciene
Egle Rinkeviciene
IKInga Katiniene
Inga Katiniene
VMValdonė Misevičienė
Valdonė Misevičienė
Background and Objectives: Sleep-related breathing disorders (SRBDs) are common but often underdiagnosed in children. Early identification is essential, as untreated pediatric SRBDs can lead to cognitive, metabolic, and cardiovascular complications. This study aimed to estimate the prevalence of children at risk for SRBDs, defined as those screening positive based on Pediatric Sleep Questionnaire (PSQ) scores, and to analyze the association with potential risk factors in the general pediatric population of Lithuania. Materials and Methods: This cross-sectional study included 1929 children aged 2–17 years. Parents completed a questionnaire covering demographics, health status, and the PSQ. A validated Lithuanian version of the PSQ was used, with ≥8 (40%) positive responses indicating suspected SRBDs. Results: Overall, 14.9% of children were suspected of having SRBDs, with the highest prevalence among those aged 7–11 years (17.5%), followed by 2–6 years (14.9%) and ≥12 years (12.6%) (p = 0.032). In preschoolers (2–6 years), the strongest predictors were attention deficit hyperactivity disorder (ADHD; p < 0.001, OR 4.456, 95% CI 1.992–9.968) and allergic rhinitis (p < 0.001, OR 2.268, 95% CI 1.433–3.591). In children aged 7–11 years, endocrine diseases showed the strongest association (p < 0.001, OR 13.366, 95% CI 2.914–61.313), followed by ADHD (p = 0.001, OR 5.693, 95% CI 1.981–16.363) and adenotonsillar hypertrophy (p < 0.001, OR 3.079, 95% CI 1.839–5.156). In adolescents (≥12 years), SRBDs were primarily associated with ADHD (p < 0.001, OR 17.513, 95% CI 9.597–31.961) and endocrine diseases (p < 0.001, OR 6.214, 95% CI 2.965–13.020), while obesity remained significant (p < 0.001, OR 3.400, 95% CI 2.106–5.489). Conclusions: Approximately 15% of Lithuanian children were at risk for SRBDs. Risk factors differed by age: adenotonsillar hypertrophy in school-aged children, allergic rhinitis in preschoolers, and obesity in adolescents, whereas ADHD was associated across age groups.